Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

1.

Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.

Martorelli D, Houali K, Caggiari L, Vaccher E, Barzan L, Franchin G, Gloghini A, Pavan A, Da Ponte A, Tedeschi RM, De Re V, Carbone A, Ooka T, De Paoli P, Dolcetti R.

Int J Cancer. 2008 Sep 1;123(5):1100-7. doi: 10.1002/ijc.23621.

PMID:
18546263
[PubMed - indexed for MEDLINE]
2.

Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.

Pasini E, Caggiari L, Dal Maso L, Martorelli D, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, De Re V, Sacchi N, Serraino D, Carbone A, Rosato A, Dolcetti R.

Int J Cancer. 2009 Sep 15;125(6):1358-64. doi: 10.1002/ijc.24515.

PMID:
19536817
[PubMed - indexed for MEDLINE]
3.

Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.

Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ.

J Med Virol. 2002 Jul;67(3):359-63.

PMID:
12116028
[PubMed - indexed for MEDLINE]
4.

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.

Taylor GS, Haigh TA, Gudgeon NH, Phelps RJ, Lee SP, Steven NM, Rickinson AB.

J Virol. 2004 Jan;78(2):768-78.

PMID:
14694109
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

Duraiswamy J, Sherritt M, Thomson S, Tellam J, Cooper L, Connolly G, Bharadwaj M, Khanna R.

Blood. 2003 Apr 15;101(8):3150-6. Epub 2002 Dec 5.

PMID:
12468425
[PubMed - indexed for MEDLINE]
Free Article
6.

Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.

Kienzle N, Sculley TB, Poulsen L, Buck M, Cross S, Raab-Traub N, Khanna R.

J Virol. 1998 Aug;72(8):6614-20.

PMID:
9658107
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.

Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.

Oncol Rep. 2004 Oct;12(4):725-31.

PMID:
15375491
[PubMed - indexed for MEDLINE]
8.
9.

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.

Gottschalk S, Edwards OL, Sili U, Huls MH, Goltsova T, Davis AR, Heslop HE, Rooney CM.

Blood. 2003 Mar 1;101(5):1905-12. Epub 2002 Oct 31.

PMID:
12411306
[PubMed - indexed for MEDLINE]
Free Article
10.

Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.

Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.

Eur J Immunol. 2006 Mar;36(3):593-602.

PMID:
16479544
[PubMed - indexed for MEDLINE]
11.

Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.

Tanner JE, Wei MX, Alfieri C, Ahmad A, Taylor P, Ooka T, Menezes J.

J Infect Dis. 1997 Jan;175(1):38-46.

PMID:
8985194
[PubMed - indexed for MEDLINE]
Free Article
13.

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S.

J Clin Oncol. 2005 Dec 10;23(35):8942-9. Epub 2005 Oct 3.

PMID:
16204009
[PubMed - indexed for MEDLINE]
14.

Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.

Lin HJ, Cherng JM, Hung MS, Sayion Y, Lin JC.

J Biomed Sci. 2005 Dec;12(6):925-36. Epub 2005 Nov 24.

PMID:
16307312
[PubMed - indexed for MEDLINE]
15.

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells.

Lee SP, Chan AT, Cheung ST, Thomas WA, CroomCarter D, Dawson CW, Tsai CH, Leung SF, Johnson PJ, Huang DP.

J Immunol. 2000 Jul 1;165(1):573-82.

PMID:
10861098
[PubMed - indexed for MEDLINE]
Free Article
16.

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB.

J Immunol. 1997 Apr 1;158(7):3325-34.

PMID:
9120290
[PubMed - indexed for MEDLINE]
17.

Computational prediction and identification of Epstein-Barr virus latent membrane protein 2A antigen-specific CD8+ T-cell epitopes.

Wang B, Yao K, Liu G, Xie F, Zhou F, Chen Y.

Cell Mol Immunol. 2009 Apr;6(2):97-103. doi: 10.1038/cmi.2009.13.

PMID:
19403058
[PubMed - indexed for MEDLINE]
Free Article
18.

Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.

Fogg MH, Wirth LJ, Posner M, Wang F.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3318-23. doi: 10.1073/pnas.0813320106. Epub 2009 Feb 11.

PMID:
19211798
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

Meij P, Leen A, Rickinson AB, Verkoeijen S, Vervoort MB, Bloemena E, Middeldorp JM.

Int J Cancer. 2002 May 1;99(1):93-9.

PMID:
11948498
[PubMed - indexed for MEDLINE]
20.

Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells.

Khanna R, Busson P, Burrows SR, Raffoux C, Moss DJ, Nicholls JM, Cooper L.

Cancer Res. 1998 Jan 15;58(2):310-4.

PMID:
9443410
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk